Supplementation in Children with CKD
Children with chronic kidney disease require targeted supplementation with vitamin D (ergocalciferol or cholecalciferol), calcium (100-200% of DRI), and zinc, while avoiding routine supplementation of vitamins A, E, selenium, and omega-3 fatty acids due to lack of benefit or potential toxicity. 1
Vitamin D Supplementation
Vitamin D deficiency is present in 80-90% of children with CKD and must be aggressively corrected to prevent secondary hyperparathyroidism and bone disease 1. The approach is stratified by severity:
Treatment Protocol by Serum 25(OH)D Level:
- Severe deficiency (<5 ng/mL): 8,000 IU/day for 4 weeks, then 4,000 IU/day for 2 months
- Mild deficiency (5-15 ng/mL): 4,000 IU/day for 12 weeks
- Insufficiency (16-30 ng/mL): 2,000 IU/day until replete
- Maintenance (once >30 ng/mL): 200-1,000 IU/day continuously 1
Critical caveat: Use ergocalciferol (D2) or cholecalciferol (D3) only—never use calcitriol, alfacalcidol, or other active vitamin D analogs for treating 25(OH)D deficiency 1. Cholecalciferol has higher bioefficacy than ergocalciferol 1.
Monitoring Requirements:
- Measure 25(OH)D annually in all CKD stages 1
- Check calcium and phosphorus 1 month after initiating/changing dose, then every 3 months 1
- Hypercalcemia indicates excessive dosing 1
Calcium Management
Total oral/enteral calcium intake (diet plus binders) should be 100-200% of DRI for age 1. This is a delicate balance:
- Lower end (100% DRI) prevents soft-tissue calcification and vascular disease
- Upper end (200% DRI) ensures adequate bone mineralization
- In oligoanuric dialysis patients: Consider further restriction below 100% DRI since urinary calcium excretion is absent and excess calcium precipitates in soft tissues 1
Reduce calcium-based phosphate binders in patients with low PTH (adynamic bone disease) 1.
Phosphorus Control
Dietary phosphorus restriction is mandatory when PTH is elevated 1:
- If serum phosphorus is normal: Restrict to 100% of DRI
- If serum phosphorus is elevated: Restrict to 80% of DRI
Monitor phosphorus every 3 months in CKD stages 3-4, monthly in stage 5/5D 1.
Iron, Folate, and Vitamin B12
Supplement only when deficiency is documented by clinical signs/symptoms and laboratory confirmation 2. The 2020 KDOQI guidelines for adults recommend:
- Folate and B12 supplementation for documented deficiency/insufficiency (not for routine hyperhomocysteinemia treatment)
- Avoid routine B-complex supplementation without indication 2
While pediatric-specific data are limited, targeted supplementation based on documented deficiency is reasonable 3.
Vitamin C
Supplement to meet 90 mg/day (males) or 75 mg/day (females) if at risk for deficiency 2. Vitamin C deficiency risk increases with dietary restrictions in CKD.
Zinc
Zinc deficiency occurs in 35% of pediatric CKD patients 3. Supplement to meet DRI when:
- Serum zinc levels are low (monitor annually)
- Clinical manifestations of deficiency are present
- Low-protein diets are prescribed 1
Do not routinely supplement without documented deficiency 1.
Supplements to AVOID
Vitamin A and E
Do not routinely supplement due to toxicity risk in CKD 5D 1, 2. These fat-soluble vitamins accumulate with impaired renal clearance. Only 67% of children maintain normal vitamin E levels, but routine supplementation causes more harm than benefit 1.
Selenium
Do not routinely supplement 1, 2. Despite 15% of children having low levels, supplementation shows minimal benefit on glutathione peroxidase activity in dialysis patients 1.
Omega-3 Fatty Acids
Do not routinely prescribe for AV graft/fistula patency or graft survival 2. Evidence shows no benefit in adults, and pediatric data are lacking.
Copper
Supplementation rarely needed—85% of children maintain normal levels 3. Monitor every 4-6 months only if dietary intake is severely restricted 1.
Practical Implementation Algorithm
- Measure baseline: 25(OH)D, calcium, phosphorus, zinc, PTH
- Initiate vitamin D based on 25(OH)D level (see protocol above)
- Adjust calcium intake to 100-200% DRI (lower if oligoanuric)
- Restrict phosphorus if PTH elevated (100% DRI if normal phosphorus, 80% if elevated)
- Supplement zinc only if documented deficiency
- Avoid vitamins A, E, selenium, omega-3s routinely
- Monitor: 25(OH)D yearly; calcium/phosphorus every 3 months; zinc annually
Common Pitfalls
- Using active vitamin D analogs (calcitriol, doxercalciferol) to treat 25(OH)D deficiency—this is incorrect 1
- Over-supplementing calcium in anuric patients, leading to vascular calcification 1
- Routine multivitamin use without assessing individual needs—this causes vitamin A/E toxicity 1, 2
- Ignoring vitamin D maintenance after repletion—deficiency recurs without 200-1,000 IU/day 1
The evidence base is strongest for vitamin D and calcium management from the 2009 KDOQI pediatric guidelines [1-1, with adult 2020 guidelines 2 providing additional micronutrient guidance applicable to children. Recent pediatric studies 3 confirm high rates of vitamin D and zinc deficiency requiring targeted supplementation.